Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Principia Biopharma, Inc.

http://www.principiabio.com/

Latest From Principia Biopharma, Inc.

Sanofi Hits M&A Trail Again To Buy UK's KyMab

Another UK biotech has been swallowed up by a big pharma with Sanofi acquiring the Cambridge-based firm in a deal that could be worth almost $1.5bn.

M & A Immune Disorders

Sanofi Grapples With Pandemic, Growing Clinical Trials, Implementing Acquisitions

Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.

Coronavirus COVID-19 Clinical Trials

GSK Venture Capital Arm Goes Independent With $500m Fund

Having been under GSK's umbrella since 1985, SR One is striking out on its own, having closed the largest first-time VC fund this year.

Financing Strategy

Sanofi Nabs Priority Review For New Pompe Drug

The French drugmaker's follow up to Myozyme – avalglucosidase alfa – is in line for a potential US approval by May next year after the US FDA agreed to a speedy review of the enzyme replacement therapy, unlike its European counterparts.

Rare Diseases Drug Review
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • ADMET
UsernamePublicRestriction

Register